Abstract
AbstractInterleukins (ILs), key cytokine family of inflammatory response, are closely associated with kidney function. However, the causal effect of various ILs on kidney function needs further investigation. Here we show two-sample summary-level Mendelian randomization (MR) analysis that examined the causality between serum IL levels and kidney function. Genetic variants with strong association with serum IL levels were obtained from a previous genome-wide association study meta-analysis. Summary-level data for estimated glomerular filtration rate (eGFR) were obtained from CKDGen database. As a main MR analysis, multiplicative random-effects inverse-variance weighted method was performed. Pleiotropy-robust MR analysis, including MR-Egger with bootstrapped error and weighted median methods, were also implemented. We tested the causal estimates from nine ILs on eGFR traits. Among the results, higher genetically predicted serum IL-1 receptor antagonist level was significantly associated with higher eGFR values in the meta-analysis of CKDGen and the UK Biobank data. In addition, the result was consistent towards eGFR decline phenotype of the outcome database. Otherwise, nonsignificant association was identified between other genetically predicted ILs and eGFR outcome. These findings support the clinical importance of IL-1 receptor antagonist-associated pathway in relation to kidney function in the general individuals, particularly highlighting the importance of IL-1 receptor antagonist.
Funder
National Research Foundation of Korea (NRF) grant, funded by the Korea government (MSIT)
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference63 articles.
1. Ramesh, G. & Reeves, W. B. Inflammatory cytokines in acute renal failure. Kidney Int. Suppl. S56–S61. https://doi.org/10.1111/j.1523-1755.2004.09109.x (2004)
2. Ye, S., Ozgur, B. & Campese, V. M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int. 51, 722–727 (1997).
3. Bidani, A. K. & Griffin, K. A. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 44, 595–601 (2004).
4. Golestaneh, L. et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am. J. Manag. Care 23, S163–s172 (2017).
5. Amdur, R. L. et al. Inflammation and progression of CKD: the CRIC study. Clin. J. Am. Soc. Nephrol. 11, 1546–1556 (2016).